Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr James Lordan

Newcastle AuthorsTitleYearFull text
Dr James Lordan
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: An interventional open-label study2019
Dr James Lordan
Patient outcomes from time of listing for lung transplantation in the UK: Are there disease-specific differences?2019
Eleni Sofianopoulou
Dr James Lordan
Emeritus Professor Paul Corris
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis2019
Dr Christopher Ward
Professor Jeffrey Pearson
Dr James Lordan
Professor Anthony De Soyza
A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk2018
Dr James Lordan
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial2018
Dr Jodie Birch
Dr Katy Hester
Dr Gareth Parry
Professor Kate Gould
Professor John Dark
et al.
Outcomes of lung transplantation in adults with bronchiectasis2018
Sasiharan Sithamparanathan
Dr Logan Thirugnanasothy
Professor Andrew Fisher
Dr James Lordan
Professor Paul Corris
et al.
Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry2017
Professor Paul Corris
Dr James Lordan
The CRASH report: Emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension2017
Dr James Lordan
Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)2016
Dr James Lordan
A combination of two novel alpha globin variants Hb Bridlington (HBA1) and Hb Taybe (HBA2) resulting in severe hemolysis, pulmonary hypertension, and death2015
123